These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 8749599

  • 1. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J, Exalto N, Dieben T, Bennink HC.
    Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
    [Abstract] [Full Text] [Related]

  • 2. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 3. Ovarian activity during regular oral contraceptive use.
    Crosignani PG, Testa G, Vegetti W, Parazzini F.
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [Abstract] [Full Text] [Related]

  • 4. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B.
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [Abstract] [Full Text] [Related]

  • 5. Ovarian function during low-dose oral contraceptive use.
    Egarter C, Putz M, Strohmer H, Speiser P, Wenzl R, Huber J.
    Contraception; 1995 Jun; 51(6):329-33. PubMed ID: 7554971
    [Abstract] [Full Text] [Related]

  • 6. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 7. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 8. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM, Fauser BC.
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [Abstract] [Full Text] [Related]

  • 9. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J.
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [Abstract] [Full Text] [Related]

  • 10. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Apr; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 11. Enlarged follicles in women using oral contraceptives.
    Broome M, Clayton J, Fotherby K.
    Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
    [Abstract] [Full Text] [Related]

  • 12. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 13. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
    Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P.
    Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
    [Abstract] [Full Text] [Related]

  • 14. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 15. Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.
    Wenzl R, Bennink HC, van Beek A, Spona J, Huber J.
    Fertil Steril; 1993 Oct; 60(4):616-9. PubMed ID: 8405513
    [Abstract] [Full Text] [Related]

  • 16. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K, Lähteenmäki P.
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [Abstract] [Full Text] [Related]

  • 17. Ultrasound evaluation of ovarian activity under oral contraceptives.
    Hoogland HJ, Skouby SO.
    Contraception; 1993 Jun; 47(6):583-90. PubMed ID: 8334892
    [Abstract] [Full Text] [Related]

  • 18. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ, Deville JL, Dubois M.
    Curr Med Res Opin; 1983 Nov; 8(6):395-404. PubMed ID: 6406157
    [Abstract] [Full Text] [Related]

  • 20. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
    Kuhl H, Gahn G, Romberg G, März W, Taubert HD.
    Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.